Search Results for "Ondansetron Im"

09:38 EST 31st January 2015 | BioPortfolio

Original Source: ONDANSETRON [Ranbaxy Pharmaceuticals Inc.]

Matching Channels


Matching News

Ondansetron for the Treatment of IBS With Diarrhea

Is ondansetron a safe and effective drug for reducing the incidence of diarrhea in patients with IBS? Gut

Drug interaction identified for ondansetron, tramadol

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Ana...

Ondansetron: Phase III started

Ipca slumps after US import alert, ripple effect fears

The import alert published on 22 January cites good manufacturing practice (GMP) problems at the site and covers all drugs except four products – trimethoprim, ondansetron and hydroxychloroquine...

RedHill begins Phase III RHB-102 trial to treat gastroenteritis

RedHill Biopharma has initiated a Phase III clinical trial of RHB-102, an oral, extended-release, once-daily formulation of the antiemetic drug ondansetron, to treat patients suffering from acute gast...

Galena Biopharma licenses US rights to MonoSol Rx's Zuplenz

Galena Biopharma Inc. (oncology) licensed exclusive US rights to drug delivery firm MonoSol Rx LLC’s Zuplenz, a marketed oral ondansetron film product for nausea and vomiting related to chemotherapy...

Data Presented at the International Society of Paediatric Oncology (SIOP) Congress Show Palonosetron is a Valuable Option for Treating Pediatric Patients Receiving Moderately to Highly Emetogenic Chemotherapy

LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 μg/kg, Palonosetron, administered as a single dose, is as effective as ondansetron...

Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015

PHOENIX, AZ -- (Marketwired) -- 01/12/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced progress and expected milestones for multiple projects in its pipeline of innovative supportive car...

Matching PubMed Articles

Prevention versus treatment of intrathecal morphine-induced pruritus with ondansetron.

Intrathecal morphine is used for post-cesarean analgesia, but pruritus is a common side effect. Ondansetron would be an attractive treatment because it prevents nausea, is non-sedative or has no anti-...

Integration of Modeling and Simulation to Support Changes to Ondansetron Dosing Following A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study.

Prolongation of the QT interval has been observed with ondansetron and other members of the 5-HT3 antagonist class. This is the first thorough QTc study of ondansetron conducted in accordance with ICH...

Comparison of ondansetron and meperidine for treatment of postoperative shivering: a randomized controlled clinical trial.

The involved neurotransmitter pathways in the postoperative shivering (POS) are poorly understood. Recently, 5-hydroxytryptamine 3 (5-HT3) receptor antagonists have been reported to prevent POS. We in...

Ondansetron reducing pain on injection of etomidate: a controlled randomized study.

Etomidate causes pain when injected intravenously. In this study we sought to determine if pretreatment by ondansetron reduces the pain on injection of etomidate.

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder.

The aim of this study was to investigate the efficacy and safety of ondansetron as an augmentative agent to fluvoxamine in the treatment of patients with obsessive-compulsive disorder (OCD). Forty-six...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement